Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 125
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Chem Biodivers ; 19(9): e202200495, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35856892

RESUMEN

OBJECT: Edible Brown Seaweed Sargassum fusiforme (Harvey) Setchell, 1931 abbreviated as Sargassum fusiforme was used for folk medical therapy in East Asia countries over five hundred years. Saringosterol acetate (SA) was isolated from S. fusiforme in our previous study and indicated various effects. However, anti-obesity activity of SA and its mechanism still unknown. METHOD: The inhibitory effect of SA, isolated from S. fusiforme, on adipogenesis in 3T3-L1 adipocytes was investigated in vitro and in zebrafish model. Cell toxicity, differentiation, signaling pathway, and lipid accumulation of SA treated 3T3-L1 adipocytes were determined. The body weight and triglyceride content of diet-induced obese (DIO) adult male zebrafish were measured from 12 to 17 weeks after fertilization. RESULT: SA attenuated the differentiation of cells and reduced lipid accumulation, and triglyceride content in the 3T3-L1 adipocytes. During the differentiation of adipocytes, SA suppressed fat accumulation and decreased the expression of signal factors responsible for adipogenesis. In SA-treated adipocytes, while fatty acid synthetase was downregulated, AMP-activated protein kinase (AMPK) was upregulated. Furthermore, SA suppressed body weight and triglyceride content in DIO zebrafish. CONCLUSION: SA is a potential therapeutic agent in the management of metabolic disorders, such as obesity.


Asunto(s)
Proteínas Quinasas Activadas por AMP , Pez Cebra , Células 3T3-L1 , Proteínas Quinasas Activadas por AMP/metabolismo , Acetatos/farmacología , Adipogénesis , Animales , Peso Corporal , Dieta Alta en Grasa , Ácido Graso Sintasas/metabolismo , Ácido Graso Sintasas/farmacología , Ácido Graso Sintasas/uso terapéutico , Masculino , Ratones , Obesidad/tratamiento farmacológico , Estigmasterol/análogos & derivados , Estigmasterol/farmacología , Triglicéridos/metabolismo , Pez Cebra/metabolismo
2.
Phytother Res ; 36(10): 3681-3690, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35802356

RESUMEN

α-Spinasterol is a phytosterol found in various edible and non-edible plant sources. The edible plant materials containing α-spinasterol include spinach leaves, cucumber fruits, seeds of pumpkin and watermelon, argan seed oil, cactus pear seed oil and Amaranthus sp. It is a bioavailable nutraceutical, and it can cross the blood-brain barrier. It possesses several important pharmacological properties such as anti-diabetes mellitus, antiinflammation, hypolipidemic, antiulcer, neuroprotection, anti-pain and antitumour activities. For this review, literature search was made focusing on the pharmacological properties of α-spinasterol using PubMed and Google Scholar data bases. Recent studies show the promising antidiabetic properties of α-spinasterol. Its anti-diabetic mechanisms include enhancement of insulin secretion, reduction in insulin resistance, anti-diabetic nephropathy, increase in glucose uptake in muscle cells and inhibition of glucose absorption from intestine. Besides, it is a safe antiinflammatory agent, and its antiinflammatory mechanisms include inhibition of cyclooxygenases, antagonism of TRPV1 receptor and attenuation of proinflammatory cytokines and mediators. It is a promising and safe nutraceutical molecule for human health care. Food supplements, value-added products and nutraceutical formulations can be developed with α-spinasterol for the management of diabetes, chronic inflammatory diseases and improving general health. This review provides all scattered pharmacological studies on α-spinasterol in one place and highlights its immense value for human health care.


Asunto(s)
Fitosteroles , Antiinflamatorios/farmacología , Citocinas , Suplementos Dietéticos , Glucosa , Humanos , Hipoglucemiantes/farmacología , Fitosteroles/farmacología , Aceites de Plantas , Prostaglandina-Endoperóxido Sintasas , Estigmasterol/análogos & derivados
3.
Mar Drugs ; 19(4)2021 Mar 27.
Artículo en Inglés | MEDLINE | ID: mdl-33801706

RESUMEN

We recently found that dietary supplementation with the seaweed Sargassum fusiforme, containing the preferential LXRß-agonist 24(S)-saringosterol, prevented memory decline and reduced amyloid-ß (Aß) deposition in an Alzheimer's disease (AD) mouse model without inducing hepatic steatosis. Here, we examined the effects of 24(S)-saringosterol as a food additive on cognition and neuropathology in AD mice. Six-month-old male APPswePS1ΔE9 mice and wildtype C57BL/6J littermates received 24(S)-saringosterol (0.5 mg/25 g body weight/day) (APPswePS1ΔE9 n = 20; C57BL/6J n = 19) or vehicle (APPswePS1ΔE9 n = 17; C57BL/6J n = 19) for 10 weeks. Cognition was assessed using object recognition and object location tasks. Sterols were analyzed by gas chromatography/mass spectrometry, Aß and inflammatory markers by immunohistochemistry, and gene expression by quantitative real-time PCR. Hepatic lipids were quantified after Oil-Red-O staining. Administration of 24(S)-saringosterol prevented cognitive decline in APPswePS1ΔE9 mice without affecting the Aß plaque load. Moreover, 24(S)-saringosterol prevented the increase in the inflammatory marker Iba1 in the cortex of APPswePS1ΔE9 mice (p < 0.001). Furthermore, 24(S)-saringosterol did not affect the expression of lipid metabolism-related LXR-response genes in the hippocampus nor the hepatic neutral lipid content. Thus, administration of 24(S)-saringosterol prevented cognitive decline in APPswePS1ΔE9 mice independent of effects on Aß load and without adverse effects on liver fat content. The anti-inflammatory effects of 24(S)-saringosterol may contribute to the prevention of cognitive decline.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Antiinflamatorios/farmacología , Conducta Animal/efectos de los fármacos , Corteza Cerebral/efectos de los fármacos , Cognición/efectos de los fármacos , Nootrópicos/farmacología , Estigmasterol/análogos & derivados , Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/psicología , Animales , Proteínas de Unión al Calcio/metabolismo , Línea Celular Tumoral , Corteza Cerebral/metabolismo , Corteza Cerebral/fisiopatología , Modelos Animales de Enfermedad , Humanos , Masculino , Ratones Endogámicos C57BL , Ratones Transgénicos , Proteínas de Microfilamentos/metabolismo , Microglía/efectos de los fármacos , Microglía/metabolismo , Reconocimiento en Psicología/efectos de los fármacos , Estigmasterol/farmacología
4.
Behav Pharmacol ; 32(4): 308-320, 2021 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-33491993

RESUMEN

Alterations of monoamine transmission in mesocorticolimbic regions have been suggested in the pathophysiology of attention deficit/hyperactivity disorder (ADHD). The habenula is an important brain area in regulation of monoamine transmission. In this study, we investigated behavioral and electrophysiological alterations induced by neonatal habenula lesion (NHL) in rats. In NHL rats, age-dependent behavioral alterations relevant to the ADHD symptoms, such as hyperlocomotion, impulsivity, and attention deficit, were observed. Local field potentials (LFPs) in mesocorticolimbic regions of anesthetized rats were examined with in vivo electrophysiological recordings. Abnormally enhanced synchronization of slow (delta) and fast (gamma) LFP oscillations between the amygdala (AMY) and prefrontal cortex (PFC) was found in juvenile, but not in adult, NHL rats. We further examined the effects of an extract and the active compound from the perennial large brown algae Ecklonia stolonifera (ES), which have previously been demonstrated to modulate monoamine transmission, on these NHL-induced alterations. One week of ES extract treatments normalized the NHL-induced behavioral alterations, whereas the active compound fucosterol improved attention deficit and impulsivity, but not hyperlocomotion, in NHL rats. Consistent with the behavioral effects, ES extract treatments also normalized augmented AMY-PFC coupling. These results suggest that altered limbic-cortical information processing may be involved in ADHD-like behavioral alterations induced by NHL, which could be ameliorated by the natural substance, such as ES that affects monoamine transmission.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad , Atención/efectos de los fármacos , Monoaminas Biogénicas/metabolismo , Fenómenos Electrofisiológicos/efectos de los fármacos , Habénula , Conducta Impulsiva , Estigmasterol/análogos & derivados , Transmisión Sináptica/efectos de los fármacos , Animales , Animales Recién Nacidos , Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Trastorno por Déficit de Atención con Hiperactividad/metabolismo , Trastorno por Déficit de Atención con Hiperactividad/fisiopatología , Modelos Animales de Enfermedad , Habénula/metabolismo , Habénula/fisiopatología , Conducta Impulsiva/efectos de los fármacos , Conducta Impulsiva/fisiología , Phaeophyceae , Fitoquímicos/farmacología , Extractos Vegetales/farmacología , Ratas , Estigmasterol/farmacología
5.
Molecules ; 25(9)2020 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-32392823

RESUMEN

Brevicoryne brassicae is a problematic pest in cabbage and other field crops. Synthetic pesticides are used to control this pest, but they are injurious for human health and the environment. The present study aimed to purify and identify the active compounds from Citrullus colocynthis leaves with an appraisal of their efficacy against B. brassicae. Separation and purification were performed via different chromatographic techniques. Molecular analysis and chemical structures were recognized by mass spectrum (MS) and nuclear magnetic resonance (NMR), respectively. Moreover, in vitro and in vivo aphicidal activity was assessed using various concentrations, i.e., 6.25, 12.5, 25 and 50 µg/mL at 12, 24, 48 and 72 h exposure. The outcome shows that mass spectrum analyses of the purified compounds suggested the molecular formulae are C30H50O and C29H50O, C29H48O. The compounds were characterized as fernenol and a mixture of spinasterol, 22,23-dihydrospinasterol by 1H-NMR and 13C-NMR spectrum analysis. The toxicity results showed that the mixture of spinasterol and 22,23-dihydrospinasterol showed LC50 values of 32.36, 44.49 and 37.50 µg/mL by contact, residual and greenhouse assay at 72 h exposure, respectively. In contrast, fernenol recorded LC50 values as 47.99, 57.46 and 58.67 µg/mL, respectively. On the other hand, spinasterol, 22,23-dihydrospinasterol showed the highest mortality, i.e., 66.67%, 53.33% and 60% while, 30%, 23.33% and 25% mortality was recorded by fernenol after 72 h at 50 µg/mL by contact, residual and greenhouse assay, respectively. This study suggests that spinasterol, 22,23-dihydrospinasterol are more effective against B. brassicae which may be introduced as an effective and suitable substitute of synthetic chemical pesticides.


Asunto(s)
Áfidos/efectos de los fármacos , Citrullus colocynthis/química , Insecticidas/toxicidad , Hojas de la Planta/química , Sitoesteroles/toxicidad , Estigmasterol/análogos & derivados , Triterpenos/toxicidad , Animales , Insecticidas/análisis , Insecticidas/aislamiento & purificación , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/toxicidad , Sitoesteroles/análisis , Sitoesteroles/química , Sitoesteroles/aislamiento & purificación , Estigmasterol/análisis , Estigmasterol/química , Estigmasterol/aislamiento & purificación , Estigmasterol/toxicidad , Triterpenos/análisis , Triterpenos/química , Triterpenos/aislamiento & purificación
6.
Phytomedicine ; 69: 153201, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32276177

RESUMEN

BACKGROUND: Marine algae are rich in some unique biologically active secondary metabolites having diverse pharmacological benefits. Of these, sterols comprise a group of functional lipid compounds that have attracted much attention to natural product scientists. PURPOSE: This review was aimed to update information on the health effects of algae-derived phytosterols and their molecular interactions in various aspects of human health and diseases and to address some future perspectives that may open up a new dimension of pharmacological potentials of algal sterols. METHODS: A literature-based search was carried out to retrieve published research information on the potential health effects of algal phytosterols with their pharmacological mechanisms from accessible online databases, such as Pubmed, Google Scholar, Web of Science, and Scopus, using the key search terms of 'marine algae sterol' and 'health potentials such as antioxidant or anti-inflammatory or anti-Alzheimer's or anti-obesity or cholesterol homeostasis or hepatoprotective, antiproliferative, etc.' RESULTS: Phytosterols of marine algae, particularly fucosterol, have been investigated for a plethora of health benefits, including anti-diabetes, anti-obesity, anti-Alzheimer's, antiaging, anticancer, and hepatoprotection, among many others, which are attributed to their antioxidant, anti-inflammatory, immunomodulatory and cholesterol-lowering properties, indicating their potentiality as therapeutic leads. These sterols interact with enzymes and various other proteins that are actively participating in different cellular pathways, including antioxidant defense system, apoptosis and cell survival, metabolism, and homeostasis. CONCLUSION: In this review, we briefly overview the chemistry, pharmacokinetics, and distribution of algal sterols, and provide critical insights into their potential health effects and the underlying pharmacological mechanisms, beyond the well-known cholesterol-lowering paradigm.


Asunto(s)
Fitosteroles/química , Fitosteroles/farmacología , Algas Marinas/química , Antiinflamatorios/química , Antiinflamatorios/farmacología , Antioxidantes/química , Antioxidantes/farmacología , Organismos Acuáticos , Colesterol/metabolismo , Humanos , Phaeophyceae/química , Fitosteroles/análisis , Fitosteroles/farmacocinética , Rhodophyta/química , Estigmasterol/análogos & derivados , Estigmasterol/farmacología , Distribución Tisular
7.
Phytomedicine ; 61: 152809, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31035050

RESUMEN

BACKGROUND: Phytochemicals have attained tremendous attention as the chemo-preventive and chemotheruptic agents. Fucosterol is a phytosterol that in prevalently found in marine algae and many other plant species. Previous studies have indicated the potential of fucosterol as an anticancer agent. However, the information on the anticancer activity of fucosterol against lung cancer as well as several other types of cancers is scantly. PURPOSE: The present study was designed to investigate the anticancer activity of fucosterol against a panel of lung cancer cell lines. METHODS: MTT and colony formation assays were used to determine the cell viability. DAPI and annexin V/PI staining assays were used for the detection of apoptosis. Cell cycle analysis was performed by flow cytometery. Boyden chamber assay was used to monitor cell migration and western blot analysis was used to determine the protein expression. In vivo evaluation was carried out in xenografted mice models. RESULTS: The results indicated that fucosterol inhibits the growth of the lung cancer cell lines. However, the anticancer effects were more profound against the A549 and SK-LU-1 cancer cells (IC50, 15 µM). In contrast, the anticancer effects of fucosterol on the non-cancerous lung cell lines were minimal. Further investigation revealed that the anticancer effects of fucosterol on the A549 and SK-LU-1 cells are due to the induction of apoptosis. Fucosterol significantly enhanced the expression of Bax and cleaved caspase-3 which was concomitant with decline in the expression of Bcl-2. Fucosterol also triggered G2/M cell cycle arrest of the A549 and SK-LU-1 cells which was associated with decrease in the expression of Cdc2, Cyclin A, Cyclin B1 and upregulation of the negative regulators of cell cycle progression (p21Cip1, and p27Kip1). Moreover, fucosterol could also inhibit the invasion of A549 and SK-LU-1 cells. Finally fucosterol could also inhibit the growth of xenografted tumours in mice. CONCLUSION: Taken together, fucosterol inhibits the growth of lung cancer cells and may prove to be a lead molecule for the treatment of lung cancer.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/patología , Estigmasterol/análogos & derivados , Animales , Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Puntos de Control del Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Humanos , Neoplasias Pulmonares/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Masculino , Ratones Endogámicos C57BL , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Estigmasterol/farmacología , Ensayos Antitumor por Modelo de Xenoinjerto , Quinasas raf/metabolismo
8.
Z Naturforsch C J Biosci ; 74(5-6): 145-150, 2019 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-30721147

RESUMEN

Phytochemical investigation of Polyscias guilfoylei leaves extract (PGE) led to the isolation of nine compounds, that is, ent-labda-8(17),13-diene-15,18-diol (1), stigmasterol (2), spinasterol (3), N-(1,3-dihydroxyoctadecan-2-yl) palmitamide (4), panaxydiol (5), 3-O-ß-d-glucopyranosylstigmasta-5,22-diene-3-ß-ol (6), (8Z)-2-(2 hydroxypentacosanoylamino) octadeca-8-ene-1,3,4-triol (7), 4-hydroxybenzoic acid (8), and tamarixetin 3,7-di-O-α-L-rhamnopyranoside (9). Compound 4 is reported in this study for the first time in nature whereas compound 9 is reported for the second time. Structural elucidation of the compounds was carried out using Nuclear Magnetic Resonance and Electrospray Ionization coupled with Mass Spectrometry spectroscopic analyses. PGE and compounds 4 and 9 exhibited weak cytotoxicity against both MCF-7 and HCT-116 cell lines using 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide assay. The antimicrobial activity of PGE and compounds 4 and 9 was evaluated using the agar diffusion method. Escherichia coli was the most susceptible Gram-negative bacteria toward PGE with a minimum inhibitory concentration value of 9.76 µg/mL, whereas compounds 4 and 9 did not show any antimicrobial activity. Compound 4 exhibited promising inhibition of histamine release using U937 human monocytes with an IC50 value of 38.65 µg/mL.


Asunto(s)
Antiinfecciosos/química , Antineoplásicos/química , Araliaceae/química , Antagonistas de los Receptores Histamínicos/química , Extractos Vegetales/química , Antiinfecciosos/farmacología , Antineoplásicos/farmacología , Disacáridos/química , Disacáridos/farmacología , Diinos/química , Diinos/farmacología , Bacterias Gramnegativas/efectos de los fármacos , Células HCT116 , Antagonistas de los Receptores Histamínicos/farmacología , Humanos , Células MCF-7 , Extractos Vegetales/farmacología , Hojas de la Planta/química , Quercetina/análogos & derivados , Quercetina/química , Quercetina/farmacología , Estigmasterol/análogos & derivados , Estigmasterol/farmacología
9.
Steroids ; 139: 18-27, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30217788

RESUMEN

Ichnocarpus frutescens, a climber plant, is distributed all over India. As its different parts are used as anti-inflammatory agent, so we re-investigated the roots to isolate compounds and evaluate its biological efficacy. Also, in-silico molecular docking was carried out to elucidate the structure activity relationship (SAR) of isolated compounds toward identifies the drug target enzyme with validation, which was further supported by anti-inflammatory in-vitro and in-vivo experimental models. The compounds have been undertaken mainly to investigate the anti-inflammatory and analgesic efficacy along with molecular docking investigation followed by anti-proteinase, anti-denaturation and cyclooxygenase (COX) inhibition studies. Inflammatory cytokines like TNF-α and IL-6 were assayed from lipopolysaccharides (LPS) and Concavallin (CON A) stimulated human PBMC derived macrophages by Enyme linked immune sorbent assay (ELISA) method. The purity index of the lead compound was determined by HPLC. The compounds were illustrated as 2-hydroxy tricosanoic acid (1), stigmasterol glucoside (2), stigmasterol (3), ß-sitosterol (4) and ß-sitosterol glucoside (5). The test molecules showed significant anti-denaturation, anti-proteinase and analgesic effect validated with docking study. Compounds exhibited anti-inflammatory and pain killing action due to dexamethasone like phytosterol property. Promising anti-denaturation and anti-proteinase activity offered by the compound 5, may hold its promise to fight against arthritis by rejuvenating the osteoblast cells and destroying the bone-resorpting complex of hydrated protein, bone minerals by secreting the acid and an enzyme collagenase along with pain management. The lead bioactive compound i.e. ß-sitosterol glucoside (compound 5) demonstrated considerable anti-inflammatory activity showing more than 90% protection against the inflammatory cytokines at 50 µM dose. The anti-denaturation and COX-2 inhibition shown by the compound 5 was also noteworthy with the significant IC50 (ranging from 0.25 to 2.56 µM) that also supporting its future promise for developing as anti-inflammatory agent. Since the most bio-active compound (5) elicit promising acute anti-inflammatory action and peripheral anti-nociceptive pain killing action with a significant ED50 dose of 3.95 & 2.84 mg/kg i.p. respectively in the in-vivo animal model. It could suggest its potentiality as a good in-vivo bio available agent to be an emerging anti-inflammatory drug regimen scaffold in the future. It also establishes significant in-vitro and in-vivo result co-relation. Therefore, the compound 5 could be believed as a potent lead for designing anti-inflammatory, anti-arthritic drug or pain killer without showing any untoward effect.


Asunto(s)
Apocynaceae/química , Inflamación/tratamiento farmacológico , Dolor Nociceptivo/tratamiento farmacológico , Esteroides/administración & dosificación , Analgésicos/farmacología , Antiinflamatorios/farmacología , Citocinas/metabolismo , Ácidos Grasos Insaturados/química , Ácidos Grasos Insaturados/aislamiento & purificación , Glucósidos/química , Glucósidos/aislamiento & purificación , Humanos , Inflamación/patología , Interleucina-6/genética , Leucocitos Mononucleares/efectos de los fármacos , Lipopolisacáridos/química , Macrófagos/efectos de los fármacos , Simulación del Acoplamiento Molecular , Dolor Nociceptivo/patología , Percepción del Dolor/efectos de los fármacos , Extractos Vegetales/química , Extractos Vegetales/farmacología , Raíces de Plantas/química , Sitoesteroles/química , Sitoesteroles/aislamiento & purificación , Esteroides/química , Esteroides/aislamiento & purificación , Estigmasterol/análogos & derivados , Estigmasterol/química , Estigmasterol/aislamiento & purificación , Factor de Necrosis Tumoral alfa/genética
10.
Food Chem ; 255: 147-156, 2018 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-29571460

RESUMEN

The functional chemical substances and the antioxidant activity of lipids in 21 marine algae along the Japanese coast were investigated. Principal component analysis was performed to detect any correlation between the chemical substances and algae phylum. Chlorophyta contained a high level of ß-carotene. Rhodophyta contained high amounts of cholesterol, ß-sitosterol, and saturated fatty acids. Phaeophyta were rich in fucosterol, α-tocopherol, fucoxanthin, and polyphenol. Phaeophyta algae also showed the highest antioxidant activity compared with other phylum. This suggests that Phaeophyta has the greatest potential to be used as a functional food. Consumption of the beneficial Phaeophyta species, such as Eisenia arborea Areschoug and Ecklonia cava Kjellman should be encouraged as not only as food products but also as nutraceuticals and dietary supplements. These beneficial ingredients should be encouraged to be studied in depth with the possibility to develop specific formulated products target to special consumer's population with added nutritional value.


Asunto(s)
Chlorophyta/química , Alimentos Funcionales , Phaeophyceae/química , Rhodophyta/química , Antioxidantes/análisis , Antioxidantes/farmacología , Carotenoides/análisis , Suplementos Dietéticos/análisis , Ácidos Grasos/análisis , Depuradores de Radicales Libres/análisis , Depuradores de Radicales Libres/farmacología , Alimentos Funcionales/análisis , Japón , Polifenoles/análisis , Análisis de Componente Principal , Estigmasterol/análogos & derivados , Estigmasterol/análisis , Tocoferoles/análisis , Xantófilas/análisis
11.
Med Chem ; 14(6): 556-562, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29332591

RESUMEN

BACKGROUND: Chagas disease is caused by the protozoan parasite Trypanosoma cruzi. This illness is found mainly in 21 Latin American countries and an estimated 8 million people are infected worldwide. The unsatisfactory chemotherapy provokes severe toxicity and resistant strains. Medicinal plants constitute a promising source of new drugs and remedies against all kinds of disorders, mainly infectious diseases arousing interest worldwide. OBJECTIVE: The aim of this study is the isolation, structural identification and evaluation of the trypanocidal activity of samples present in the Excoecaria lucida Sw. leaves. METHODS: Total extract (TE) of E. lucida Sw. leaves was obtained by ethanol extract therefore fractionated sequentially with hexane, ethyl acetate and n-butanol, to obtain three phases: Hex, EA and But, respectively. Ellagic acid (EL1) was purified from both EA and But phases, while EL2; a 1:1 stigmasterol-3-O-ß-D-glucopyranoside plus sitosterol-3-O-ß-D-glucopyranoside mixture was obtained from the Hex phase. Activity assays were performed using bloodstream and intracellular forms of T. cruzi and cytotoxicity assays using L929 fibroblasts. RESULTS: The EL1 and EL2 samples were more active against bloodstream trypomastigote forms with EC50 of 53.0±3.6 and 58.2±29.0 µg/mL, respectively; at 100 µg/mL. These samples also showed 70% of inhibition of L929 cells infection. Toxicity assays demonstrated that after 96 h of treatment only the fractions Hex and EA presented detectable cytotoxicity. CONCLUSION: Ellagic acid, stigmasterol-3-O-ß-D-glucopyranoside and sitosterol-3-O-ß-Dglucopyranoside are reported for the first time in E. lucida Sw. leaves as well as their biological activity studies supporting further investigations for Chagas disease treatment.


Asunto(s)
Extractos Vegetales/farmacología , Tripanocidas/farmacología , 1-Butanol/química , Acetatos/química , Animales , Ácido Elágico/aislamiento & purificación , Ácido Elágico/farmacología , Ácido Elágico/toxicidad , Euphorbiaceae/química , Fibroblastos/efectos de los fármacos , Fibroblastos/microbiología , Glucósidos/aislamiento & purificación , Glucósidos/farmacología , Glucósidos/toxicidad , Hexanos/química , Ratones , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/toxicidad , Hojas de la Planta/química , Sitoesteroles/aislamiento & purificación , Sitoesteroles/farmacología , Sitoesteroles/toxicidad , Estigmasterol/análogos & derivados , Estigmasterol/aislamiento & purificación , Estigmasterol/farmacología , Estigmasterol/toxicidad , Tripanocidas/aislamiento & purificación , Tripanocidas/toxicidad , Trypanosoma cruzi/efectos de los fármacos
12.
Nat Prod Res ; 32(9): 1004-1009, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-28927288

RESUMEN

A new sesquiterpene kalinturoside A (1), and 17 known compounds friedelan-3-ol (2), 24-ethyl-5a-cholesta-7, 22(E)-dien-3-one (3), friedelin (4), syringaresinol (5), α-spinasterol (6), ciwujiatone (7), syringic acid (8), scopoletin (9), apocynin (10), 1-(3-hydroxy-4, 5-dimethoxyphenyl)ethan-1-one (11), apigenin (12), 5-hydroxymethylfurfural (13), stigmasterol-3-O-ß-d-glucopy-ranoside (14), bidenoside C (15), citrusin (16), irioresinol A (17) and syringaresinol-4-O-ß-d-glucopyranoside (18) were isolated from the herbs of Kalimeris integrifolia. The structures of these compounds were elucidated using spectroscopic techniques such as NMR and MS. All of the compounds were isolated from this genus for the first time.


Asunto(s)
Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/farmacología , Asteraceae/química , Sesquiterpenos/química , Alquinos/química , Alquinos/farmacología , Línea Celular Tumoral , Ensayos de Selección de Medicamentos Antitumorales , Medicamentos Herbarios Chinos/química , Furaldehído/análogos & derivados , Furaldehído/química , Furaldehído/farmacología , Furanos/química , Furanos/farmacología , Glucósidos/química , Glucósidos/farmacología , Humanos , Lignanos/química , Lignanos/farmacología , Espectroscopía de Resonancia Magnética , Estructura Molecular , Sesquiterpenos/farmacología , Estigmasterol/análogos & derivados , Estigmasterol/química , Estigmasterol/farmacología , Triterpenos/química , Triterpenos/farmacología
13.
Nat Prod Res ; 32(11): 1316-1319, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28637390

RESUMEN

The brown seaweed, Sargassum linearifolium (Turner) C. Agardh, 1820 is commonly available along the south-east coast of India. Its compound fucosterol was isolated and confirmed through spectral characterisation and chemical transformation methods. The antiplasmodial effect of the isolated fucosterol was investigated against the 3D7 chloroquine sensitive Plasmodium falciparum strain, parasitaemia percentage was determined at 48 h and morphological change was studied through microscopic examination after Giemsa staining. A perceptible antiplasmodial effect was produced by fucosterol compound against the P. falciparum and positive control, chloroquine with the IC50 values (µg/mL) of 7.48 and 12.81, respectively. Fucosterol showed higher antiplasmodial activity as compared to chloroquine. It is inferred that both the fucosterol and chloroquine could have inhibited the schizont stage of the parasite during the intra-erythrocyte asexual development. The findings underline the usefulness of the seaweed-based fucosterol and further studies are warranted.


Asunto(s)
Antimaláricos/química , Antimaláricos/farmacología , Plasmodium falciparum/efectos de los fármacos , Sargassum/química , Estigmasterol/análogos & derivados , Animales , Cloroquina/farmacología , Evaluación Preclínica de Medicamentos/métodos , Eritrocitos/parasitología , India , Concentración 50 Inhibidora , Parasitemia/tratamiento farmacológico , Extractos Vegetales/química , Algas Marinas/química , Estigmasterol/química , Estigmasterol/farmacología
14.
Phytother Res ; 31(11): 1694-1701, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28921681

RESUMEN

Saringosterol, a steroid isolated from Sargassum muticum, a brown edible alga widely distributed on the seashores of southern and eastern Korea, has been shown to exhibit anti-obesity effect. In this study, we investigated the anti-obesity activity of saringosterol through various experiments. The inhibitory effect of saringosterol on adipogenesis was evaluated via Oil Red O staining in 3T3-L1 preadipocytes. After confirming that saringosterol is not cytotoxic to these cells by using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay, the effect of saringosterol on the expression of various adipogenesis-related genes was analyzed via quantitative real-time polymerase chain reaction and western blotting. We demonstrated that saringosterol dose dependently inhibited adipocyte differentiation and expression of adipogenic marker genes such as adipocyte fatty acid-binding protein, adiponectin, resistin, and fatty acid synthase in 3T3-L1 cells. In addition, saringosterol significantly inhibited the mRNA and protein expression of peroxisome proliferator-activated receptor γ and CCAAT enhancer-binding protein α in 3T3-L1 cells. Collectively, these findings indicate that saringosterol isolated from S. muticum exhibits anti-obesity effect by inhibiting the expression of adipogenic transcription factors and marker genes and that it may be developed as a drug to suppress adipogenesis. Copyright © 2017 John Wiley & Sons, Ltd.


Asunto(s)
Fármacos Antiobesidad/farmacología , Extractos Vegetales/farmacología , Sargassum/química , Estigmasterol/análogos & derivados , Células 3T3-L1 , Adipocitos/efectos de los fármacos , Adipogénesis/efectos de los fármacos , Adiponectina/metabolismo , Animales , Proteína alfa Potenciadora de Unión a CCAAT/metabolismo , Diferenciación Celular/efectos de los fármacos , Ácido Graso Sintasas/metabolismo , Proteínas de Unión a Ácidos Grasos/metabolismo , Ratones , PPAR gamma/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , República de Corea , Resistina/metabolismo , Estigmasterol/farmacología , Factores de Transcripción/metabolismo
15.
Molecules ; 22(8)2017 Aug 22.
Artículo en Inglés | MEDLINE | ID: mdl-28829376

RESUMEN

Sterols play a unique role for the structural and dynamical organization of membranes. The current study reports data on the membrane properties of the phytosterol (3ß,5α,22E)-stigmasta-7,22-dien-3-ß-ol (α-spinasterol), which represents an important component of argan oil and have not been investigated so far in molecular detail. In particular, the impact of α-spinasterol on the structure and organization of lipid membranes was investigated and compared with those of cholesterol. Various membrane parameters such as the molecular packing of the phospholipid fatty acyl chains, the membrane permeability toward polar molecules, and the formation of lateral membrane domains were studied. The experiments were performed on lipid vesicles using methods of NMR spectroscopy and fluorescence spectroscopy and microscopy. The results show that α-spinasterol resembles the membrane behavior of cholesterol to some degree.


Asunto(s)
Colesterol/química , Membrana Dobles de Lípidos/química , Membranas Artificiales , Estigmasterol/análogos & derivados , Fluorescencia , Espectroscopía de Resonancia Magnética/métodos , Permeabilidad , Fosfolípidos/química , Aceites de Plantas/química , Estigmasterol/química
16.
Nat Prod Res ; 31(19): 2312-2315, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28278621

RESUMEN

Activity-guided fractionation for complement inhibitors led to the isolation of 22 known compounds from Viola kunawarensis. Chemical types include six sterol compounds, three coumarin compounds, five megastigmane compounds, two triterpenoid compounds, two phenylpropanoid compounds, one chlorophyll, one amide, and two lipid compounds. Among which, two sterols (stigmasta-4-ene-3ß,6ß-diol and saringosterone), one amide (aurantiamide acetate) and a norsesquiterpenoid (solalyratin B) exhibited better anti-complementary effects with CH50 values ranging from 0.02 to 0.08 mM, which are plausible candidates for developing potent anti-complementary agents.


Asunto(s)
Inactivadores del Complemento/aislamiento & purificación , Extractos Vegetales/aislamiento & purificación , Viola/química , Fraccionamiento Químico , Cumarinas/aislamiento & purificación , Glicósidos/aislamiento & purificación , Extractos Vegetales/química , Plantas Medicinales/química , Espirostanos/aislamiento & purificación , Esteroles/química , Esteroles/aislamiento & purificación , Estigmasterol/análogos & derivados , Estigmasterol/aislamiento & purificación , Triterpenos/aislamiento & purificación
17.
Nat Prod Res ; 31(23): 2801-2805, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28278644

RESUMEN

In this study, six known compounds 1-6 were isolated from the aerial parts of Silene arenarioides Desf. using different chromatographic methods. The structures of these compounds were identified as maltol glycoside (1), soyacerebroside I (2), chrysin (3), apigenin (4), quercetin (5) and stigmasterol glucoside (6). The compounds (1) and (2) are reported for the first time from this genus. The isolated compounds were determined using NMR techniques (1H NMR, 13C NMR, COSY, HSQC and HMBC) and mass spectroscopy (ESI-MS). The antibacterial and antioxidant activities of extracts and of compound (1) have been evaluated. The antioxidant activity was performed by DPPH radical scavenging method, which showed that methanol extract possesses a good antioxidant activity with value of IC50 = 8.064 ± 0.005 µg/mL.


Asunto(s)
Antibacterianos/química , Antibacterianos/farmacología , Antioxidantes/química , Antioxidantes/farmacología , Glicósidos/química , Glicósidos/farmacología , Silene/química , Apigenina/análisis , Apigenina/farmacología , Evaluación Preclínica de Medicamentos/métodos , Flavonoides/análisis , Flavonoides/química , Glucósidos/análisis , Glucósidos/farmacología , Espectroscopía de Resonancia Magnética , Estructura Molecular , Extractos Vegetales/química , Extractos Vegetales/farmacología , Quercetina/análisis , Quercetina/farmacología , Espectrometría de Masa por Ionización de Electrospray , Estigmasterol/análogos & derivados , Estigmasterol/análisis , Estigmasterol/farmacología
18.
Fitoterapia ; 119: 12-19, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28351722

RESUMEN

In this study, we designed a novel method of the synthesis of α-spinasterol from commercially available stigmasterol and explored the combinational effect of the α-spinasterol with ceftiofur in vitro against S. pullorum cvcc533, S. pneumoniae CAU0070, E. coli, and S. aureus. α-Spinasterol was obtained by a key reaction of Bamford-Stevens reaction with a desirable yield for five steps. The combination of α-spinasterol and ceftiofur showed stronger synergetic effect against the four pathogenic strains compared with that of stigmasterol and ceftiofur alone. In time-kill analyses, at concentrations above the MICs, ceftiofur in combination with α-spinasterol exhibited time-dependency and concentration-dependency comparing to time dependency with ceftiofur alone. We conclude that the combination usage of α-spinasterol and ceftiofur is an effective and promising strategy against the four pathogenic bacterial strains in vitro.


Asunto(s)
Antibacterianos/síntesis química , Antibacterianos/farmacología , Cefalosporinas/farmacología , Estigmasterol/análogos & derivados , Sinergismo Farmacológico , Escherichia coli/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Staphylococcus/efectos de los fármacos , Estigmasterol/síntesis química , Estigmasterol/farmacología
19.
Mar Biotechnol (NY) ; 19(1): 65-75, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28138935

RESUMEN

Hizikia fusiforme, a brown seaweed, has been utilized as a health food and in traditional medicine. In this study, we investigated whether enzyme-modified H. fusiforme extracts (EH) have immunological effects compared with normal H. fusiforme extracts (NH). The effects of NH and EH on immune responses were investigated by assessing nitric oxide (NO) production, phagocytosis, and cytokine secretion in RAW 264.7 murine macrophages and mice. Also, fucosterol was evaluated to find the active component of NH and EH by addressing cytotoxicity test and NO production. Both of NH and EH significantly increased cell viability and NO synthesis. Tumor necrosis factor-α (TNF-α) expression was more induced by EH with LPS treatment. Phagocytic activity, as the primary function of macrophages, was markedly induced by EH treatment. Additionally, EH encouraged splenocyte proliferation and recovered the levels of cytokines IL-1ß, IL-6, and TNF-α in mice. Finally, fucosterol increased NO production with no cytotoxicity, which means that fucosterol is an active component of EH. In conclusion, EH has the potential to modulate immune function and could offer positive therapeutic effect for immune system diseases.


Asunto(s)
Factores Inmunológicos/farmacología , Linfocitos/efectos de los fármacos , Phaeophyceae/química , Fagocitosis/efectos de los fármacos , Algas Marinas/química , Estigmasterol/análogos & derivados , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Expresión Génica , Factores Inmunológicos/aislamiento & purificación , Interleucina-1beta/genética , Interleucina-1beta/inmunología , Interleucina-6/genética , Interleucina-6/inmunología , Lipopolisacáridos/antagonistas & inhibidores , Lipopolisacáridos/farmacología , Linfocitos/citología , Linfocitos/inmunología , Macrófagos/citología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Ratones , Óxido Nítrico/agonistas , Óxido Nítrico/biosíntesis , Cultivo Primario de Células , Estigmasterol/aislamiento & purificación , Estigmasterol/farmacología , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología
20.
Nat Prod Res ; 31(22): 2581-2586, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28135873

RESUMEN

A new compound, methylbergenin (1), was isolated from the whole plants of Ardisia japonica (Thunb.) Bl. (Myrsinaceae), along with eight known compounds: demethoxybergenin (2), bergenin (3), afzelin (4), quercitrin (5), bauerenol (6), bauerenone (7), α-spinasterol (8) and chondrillasterone (9). Compounds 1, 7 and 9 were isolated from A. japonica for the first time. The structure of compound 1 was determined on the basis of NMR (1D and 2D) and mass spectroscopic analysis. The absolute configuration of 1 was assessed by single-crystal X-ray diffraction. Compounds 1, 4, 5, 7 and 9 showed potential inhibitory effects against nitric oxide production in LPS stimulated RAW 264.7 murine macrophages. In addition, Compounds 7 and 9 exhibited cytotoxicity against A549 and HepG-2 cells.


Asunto(s)
Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/farmacología , Ardisia/química , Animales , Benzopiranos/aislamiento & purificación , Cristalografía por Rayos X , Evaluación Preclínica de Medicamentos/métodos , Células Hep G2 , Humanos , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Espectroscopía de Resonancia Magnética , Ratones , Estructura Molecular , Óxido Nítrico/biosíntesis , Estigmasterol/análogos & derivados , Estigmasterol/aislamiento & purificación , Triterpenos/química , Triterpenos/aislamiento & purificación , Triterpenos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA